The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2025

Filed:

Nov. 11, 2020
Applicant:

Mbd Co., Ltd., Suwon-si, KR;

Inventors:

Bosung Ku, Yongin-si, KR;

Gun Hwa Kim, Daejeon, KR;

Sin Hyoung Hong, Daejeon, KR;

Min Ji Lee, Daejeon, KR;

Ji Hoon Lee, Daegu, KR;

Sang-Hyun Lee, Gyeonggi-do, KR;

Assignee:

MBD CO., LTD., Suwon-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); A23L 33/10 (2016.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A23L 33/10 (2016.08); A61P 1/16 (2018.01); A61P 3/10 (2018.01); C07D 401/14 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present invention relates to a novel quinoline compound and a use thereof and to a novel quinoline compound exhibiting CYP4A inhibition activity and a use thereof for preventing, alleviating, treating a metabolic disease. The compound disclosed in the present invention has a remarkable effect of inhibiting CYP4A and exhibits the activities of promoting the absorption of glucose into hepatocytes, inhibiting fat accumulation in hepatocytes, suppressing endoplasmic reticulum-induced reactive oxygen species, and treating steatohepatitis, and thus can be very advantageously used for developing therapeutics for metabolic diseases such as diabetes mellitus and fatty liver.


Find Patent Forward Citations

Loading…